Search results for "BLOOD-BRAIN BARRIER"

showing 10 items of 141 documents

Alkamides from Echinacea angustifolia Interact with P-Glycoprotein of Primary Brain Capillary Endothelial Cells Isolated from Porcine Brain Blood Ves…

2013

The blood-brain barrier prevents the passage of toxic compounds from blood circulation into brain tissue. Unfortunately, drugs for the treatment of neurodegenerative diseases, brain tumors, and other diseases also do not cross the blood-brain barrier. In the present investigation, we used isolated porcine brain capillary endothelial cells and a flow cytometric calcein-AM assay to analyze inhibition of P-glycoprotein, a major constituent of the blood-brain barrier. We tested 8 alkamides isolated from Echinacea angustifolia and found that four of them inhibited P-glycoprotein-mediated calcein transport in porcine brain capillary endothelial cells.

ATP Binding Cassette Transporter Subfamily BPolyunsaturated AlkamidesSwinePharmaceutical ScienceATP-binding cassette transporterCapillary endothelial cellsPharmacologyBlood–brain barrierEchinaceaAnalytical Chemistrychemistry.chemical_compoundDrug DiscoverymedicineAnimalsCells CulturedP-glycoproteinPharmacologyDose-Response Relationship DrugMolecular StructurebiologyEchinacea angustifoliaOrganic ChemistryBrainEndothelial CellsBiological TransportFlow CytometryFluoresceinsbiology.organism_classificationCalceinmedicine.anatomical_structureComplementary and alternative medicinechemistryBlood-Brain BarrierBlood circulationbiology.proteinMolecular MedicinePorcine brainPlanta Medica
researchProduct

Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics

2021

Graphical abstract

ATP Adenosine-triphosphateNBD nucleotide binding domainGSH reduced glutathionePolypharmacologyAlzheimer’s disease (AD)ATP-binding cassette transporterHTS high-throughput screeningBiochemistryABCA7Structural BiologyPLIF protein ligand interactionMSD membrane spanning domainPDB protein data bankTM transmembrane helixABC ATP-binding cassetteMultitarget modulation (PANABC)RMSD root mean square distanceABC transporter (ABCA1 ABCA4 ABCA7)Computer Science ApplicationsMOE Molecular Operating EnvironmentPharmacophoreSNP single-nucleotide polymorphismBiotechnologyResearch ArticleBBB blood-brain barrierBiophysicsDrug designComputational biologyBiologyAD Alzheimer’s diseasePET positron emission tomographyIC intracellular helixAPP amyloid precursor proteincryo-EM cryogenic-electron microscopyGeneticsHomology modelingBinding siteRational drug design and developmentComputingMethodologies_COMPUTERGRAPHICSNBD-cholesterol 7-nitro-2-13-benzoxadiazol-4-yl-cholesterolTransporterPSO particle swarm optimizationPET tracer (PETABC)ECD extracellular domainR-domain/region regulatory domain/regionABCA1biology.proteinEH extracellular helixTP248.13-248.65BODIPY-cholesterol 44-difluoro-4-bora-3a4a-diaza-s-indacene-cholesterolComputational and Structural Biotechnology Journal
researchProduct

'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET inves…

2006

Dopamine neurotransmission influences those cognitive processes, which are generally regarded as prefrontal cortical functions. In previous positron‐emission‐tomography (PET) studies, net blood‐brain clearance of [(18)F]‐fluoro‐l‐DOPA (FDOPA) correlated with impaired cognitive performance in patients with Parkinson's disease or schizophrenia. We hypothesized that FDOPA influx also correlates with performance of cognitive tasks associated with prefrontal functioning in healthy volunteers. The net blood‐brain clearance of FDOPA (K [Formula: see text]) was mapped in a group of 11 healthy volunteers and calculated in striatal volumes‐of‐interest. The Wisconsin‐Card‐Sorting‐Test (WCST), Stroop‐T…

AdultMaleElementary cognitive taskMetabolic Clearance RateDopamineCaudate nucleusPrefrontal CortexStriatumNeuropsychological Testsbehavioral disciplines and activitiesSynaptic TransmissionBasal GangliaFunctional LateralityCognitionMesencephalonReference ValuesBasal gangliaNeural PathwaysReaction TimeHumansRadiology Nuclear Medicine and imagingPrefrontal cortexResearch ArticlesBrain MappingRadiological and Ultrasound TechnologyReceptors Dopamine D2PutamenCognitive flexibilityPutamenMiddle AgedDihydroxyphenylalanineNeurologyBlood-Brain BarrierPositron-Emission TomographyNeurology (clinical)AnatomyCaudate NucleusPsychologyNeuroscienceStroop effectHuman brain mapping
researchProduct

Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans.

2021

Neuroinflammation is a pathophysiological hallmark of multiple sclerosis and has a close mechanistic link to neurodegeneration. Although this link is potentially targetable, robust translatable models to reliably quantify and track neuroinflammation in both mice and humans are lacking. The choroid plexus (ChP) plays a pivotal role in regulating the trafficking of immune cells from the brain parenchyma into the cerebrospinal fluid (CSF) and has recently attracted attention as a key structure in the initiation of inflammatory brain responses. In a translational framework, we here address the integrity and multidimensional characteristics of the ChP under inflammatory conditions and question w…

AdultMaleProteomicsEncephalomyelitis Autoimmune ExperimentalMultiple SclerosisMiceNatalizumabCerebrospinal fluidImmune systemmedicineAnimalsHumansNeuroinflammationMultidisciplinarybusiness.industryMultiple sclerosisExperimental autoimmune encephalomyelitisNeurodegenerationBrainmedicine.diseaseMagnetic Resonance ImagingMice Inbred C57BLDisease Models AnimalBlood-Brain BarrierChoroid PlexusNeuroinflammatory DiseasesChoroid plexusFemalebusinessNeurosciencemedicine.drugProceedings of the National Academy of Sciences of the United States of America
researchProduct

Consensus meeting: monosodium glutamate – an update

2006

Update of the Hohenheim consensus on monosodium glutamate from 1997: Summary and evaluation of recent knowledge with respect to physiology and safety of monosodium glutamate.Experts from a range of relevant disciplines received and considered a series of questions related to aspects of the topic.University of Hohenheim, Stuttgart, Germany.The experts met and discussed the questions and arrived at a consensus.Total intake of glutamate from food in European countries is generally stable and ranged from 5 to 12 g/day (free: ca. 1 g, protein-bound: ca. 10 g, added as flavor: ca. 0.4 g). L-Glutamate (GLU) from all sources is mainly used as energy fuel in enterocytes. A maximum intake of 6.000 [c…

AdultMalemedicine.medical_specialtyAdolescentMonosodium glutamatePopulationMedicine (miscellaneous)Physiologychemistry.chemical_compoundBolus (medicine)Elderly personsPregnancyInternal medicineSodium GlutamatemedicineHumansPalatabilityChildeducationAgedAged 80 and overeducation.field_of_studyNutrition and DieteticsDose-Response Relationship DrugAppetite Regulationbusiness.industryInfant NewbornGlutamate receptorInfantMiddle AgedFood safetyFlavoring AgentsHuman nutritionEndocrinologychemistryBlood-Brain BarrierConsumer Product SafetyChild PreschoolPrenatal Exposure Delayed EffectsFemaleFood AdditivesbusinessEuropean Journal of Clinical Nutrition
researchProduct

Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.

2006

In animal studies, acute antipsychotic treatment was shown to enhance striatal DOPA-decarboxylase (DDC) activity. However, this phenomenon has not been demonstrated in humans by positron emission tomography (PET). Therefore, we investigated acute haloperidol effects on DDC activity in humans using [18F]fluorodopa (FDOPA) PET. Nine healthy volunteers were scanned with FDOPA in drug-free baseline conditions and after 3 days of haloperidol treatment (5 mg/day). A continuous performance test (CPT) was administered in both conditions. The net blood-brain clearance of FDOPA (K(in)app) in striatum, mesencephalon, and medial prefrontal cortex was calculated by volume-of-interest analysis. The macro…

AdultMalemedicine.medical_specialtyFluorine RadioisotopesCognitive NeurosciencePrefrontal CortexStimulationStriatumNeuropsychological TestsMesencephalonInternal medicineBasal gangliamedicineHaloperidolImage Processing Computer-AssistedHumansAttentionFluorodopaPrefrontal cortexDominance Cerebralmedicine.diagnostic_testbusiness.industryPutamenBrainMiddle AgedCorpus StriatumDihydroxyphenylalanineEndocrinologyNeurologyPattern Recognition VisualPositron emission tomographyBlood-Brain BarrierPositron-Emission TomographyHaloperidolNuclear medicinebusinessPsychomotor Performancemedicine.drugNeuroImage
researchProduct

Occupancy of striatal D 2 -like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic

1999

Rationale: EMD 57445 (panamesine) is a high affinity sigma ligand with the profile of an atypical antipsychotic in animal studies. It has been reported recently to have antipsychotic activity in schizophrenia. However, its metabolite, EMD 59983, binds also to D2 and D3 dopamine (DA) receptors. Objectives: The aim of this study was to test, using single photon emission computed tomography (SPECT) and [123I]iodobenzamide (IBZM) as the radiotracer, whether EMD 59983 would pass the blood-brain barrier and to what extent it would contribute to the effects of EMD 57445 in schizophrenia. Methods: Two IBZM SPECT-scans were performed in five neuroleptic-free schizophrenic patients (DSM IV), one befo…

AdultMalemedicine.medical_specialtyPyrrolidinesmedicine.drug_classmedicine.medical_treatmentSigma receptorAtypical antipsychoticPanamesinePharmacologychemistry.chemical_compoundIodobenzamidePiperidinesDopamine receptor D3DopamineInternal medicinemedicineHumansReceptors sigmaAntipsychoticOxazolesTomography Emission-Computed Single-PhotonPharmacologyReceptors Dopamine D2Middle AgedCorpus StriatumPyrimidinesEndocrinologychemistryBlood-Brain BarrierDopamine receptorBenzamidesSchizophreniaFemaleAntipsychotic Agentsmedicine.drugPsychopharmacology
researchProduct

Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration

2000

No abstract

Adultmedicine.medical_specialtyUltrasonography Doppler Transcranialmedicine.medical_treatmentSkull NeoplasmsElectrolytesIntraoperative PeriodCerebrospinal fluidPharmacokineticsInternal medicinemedicineHumansPulseRecombinant erythropoietinErythropoietinTransplantationChemotherapybusiness.industrySettore MED/27 - NeurochirurgiaErythropoietin transcranial dopplerRecombinant ProteinsEndocrinologyCytokineBlood-Brain BarrierNephrologyErythropoietinCerebrovascular CirculationInjections IntravenousIntravenous recombinant erythropoietin; cerebrospinal fluid; erythropoietin concentration.Femalebusinessmedicine.drug
researchProduct

Mitochondrial transcriptional study of the effect of aflatoxins, enniatins and carotenoids in vitro in a blood brain barrier model

2020

C. maxima (var. Delica), a variety of pumpkin, is well known for its high concentration on carotenoids, possessing dietary benefits and antioxidant properties. Aflatoxins and enniatins are common mycotoxins present in food and feed with an extended toxicity profile in humans and animals. Both types of substances reach a wide range of tissues and organs and have the capability to penetrate the blood brain barrier. Since carotenoids and mycotoxins have been reported to modify diverse mitochondrial processes individually, transcriptional in vitro studies on human epithelial cells ECV 304 were conducted to analyze the relative expression of 13 mitochondria related genes. ECV 304 cells were diff…

AflatoxinMitochondrial DNAAntioxidantmedicine.medical_treatmentAlzheimer Antioxidants Mycotoxicity Neurodegenerative diseases Carotenoids qPCR ECV 304MitochondrionToxicologyBlood–brain barrierAntioxidantsCell LineNOchemistry.chemical_compoundAflatoxinsCucurbitaDepsipeptidesHuman Umbilical Vein Endothelial CellsmedicineHumansECV 304MycotoxinMycotoxicityCarotenoidchemistry.chemical_classificationLS9_6Neurodegenerative diseasesfood and beveragesGeneral MedicineCarotenoidsIn vitroMitochondriaqPCRmedicine.anatomical_structureElectron Transport Chain Complex ProteinschemistryBiochemistryBlood-Brain BarrierAlzheimerFood Science
researchProduct

Function of Glia in Aging and the Brain Diseases.

2019

Microglia cells during aging, neurodegeneration and neuroinflammation show different morphological and transcriptional profiles (related to axonal direction and cell adhesion). Furthermore, expressions of the receptors on the surface and actin formation compared to young are also different. This review delves into the role of glia during aging and the development of the diseases. The susceptibility of different regions of the brain to disease are linked to the overstimulation of signals related to the immune system during aging, as well as the damaging impact of these cascades on the functionality of different populations of microglia present in each region of the brain. Furthermore, a decr…

AgingDiseaseReviewBiologyBlood–brain barrier03 medical and health sciences0302 clinical medicineImmune systemmedicineHumansCell adhesionReceptorNeuroinflammationBrain DiseasesMicrogliaglia.NeurodegenerationBrainGeneral Medicinemedicine.diseasemedicine.anatomical_structureGene Expression RegulationBlood-Brain Barrier030211 gastroenterology & hepatologyMicrogliaNeuroscienceNeuroglia
researchProduct